There was a higher median NT‐proBNP level in patients admitted following the first UK COVID‐19 death (AC) compared with before (BC), but this did not reach statistical significance (4784 vs. 4495 pg/mL, respectively, P = 0.37). The gene discussed is NPPB; the disease is COVID-19.